Krystal G
Exp Hematol. 1983 Aug;11(7):649-60.
Spleens taken from B6C3F1 mice on the third day following the second of 2 daily injections of phenylhydrazine HCl (60 mg/kg) contain approximately 10 times the number of cells (i.e., 10(9) cells) found in spleens from normal mice. More than 90% of these spleen cells are recognizable erythroid and form the basis of a new in vitro microassay for erythropoietin (Ep) which uses 3H-thymidine incorporation as an endpoint. This assay takes 24 h and can be carried out in the presence of either 20% FCS or a well-defined serum substitute. Under the conditions used, Ep levels from 30 mU/well down to as little as 0.2 mU/well can be accurately measured with a corresponding variation in counts of 50-100-fold. One spleen is sufficient for 1000 triplicate Ep determinations, and the use of this microassay procedure requires only very small (1-60) microliters) samples for evaluation. Preliminary studies with human plasma suggest that this assay may be more specific for Ep than established in vitro 59Fe bioassay methods.
在连续两天每天注射盐酸苯肼(60毫克/千克)后的第三天,取自B6C3F1小鼠的脾脏所含细胞数量约为正常小鼠脾脏中细胞数量的10倍(即10⁹个细胞)。这些脾细胞中超过90%是可识别的红系细胞,构成了一种新的促红细胞生成素(Ep)体外微量测定法的基础,该方法以³H-胸腺嘧啶核苷掺入作为终点。此测定需时24小时,可在20%胎牛血清或一种明确的血清替代品存在的情况下进行。在所使用的条件下,每孔30毫单位至低至0.2毫单位的Ep水平均可准确测量,相应的计数变化为50至100倍。一个脾脏足以进行1000次一式三份的Ep测定,使用这种微量测定法仅需非常少量(1至60微升)的样品进行评估。对人血浆的初步研究表明,该测定法对Ep的特异性可能比既定的体外⁵⁹Fe生物测定法更高。